Download PDF
Dtsch Med Wochenschr 2011; 136(16): 847-849
DOI: 10.1055/s-0031-1272569
Kommentar | Commentary
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Kardiale Resynchronisationstherapie bei asymptomatischen Patienten mit schwer eingeschränkter linksventrikulärer Funktion

Cardiac resynchronisation therapy in asymptomatic patients with severely depressed left ventricular functionC. Stellbrink1
  • 1Klinik für Kardiologie und Internistische Intensivmedizin, Städtische Kliniken Bielefeld
Further Information

Publication History

eingereicht: 21.2.2011

akzeptiert: 5.4.2011

Publication Date:
06 April 2011 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

linksventrikuläre Dysfunktion - kardiale Resynchronisationstherapie - Herzinsuffizienz - biventrikuläre Stimulation

Keywords

left ventricular dysfunction - cardiac resynchronization therapy - heart failure - biventricular stimulation

Literatur

  • 1 Auricchio A, Stellbrink C, Sack S. et al . Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.  J Am Coll Cardiol. 2002;  39 2026-2033
    Google Scholar
  • 2 Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck K H. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).  Circulation. 2002;  105 1453-1458
    Google Scholar
  • 3 Bardy G H, Lee K L, Mark D B. et al . Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-237
    Google Scholar
  • 4 Brignole M, Gammage M, Puggioni E. et al, on behalf of the Optimal Pacing SITE (OPSITE) Study Investigators . Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation.  Eur Heart J. 2005;  26 712-722
    Google Scholar
  • 5 Bristow M R, Saxon L A, Boehmer J. et al . Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.  N Engl J Med. 2004;  350 2140-2150
    Google Scholar
  • 6 Cazeau S, Leclercq C, Lavergne T. et al . Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.  N Engl J Med. 2001;  344 873-880
    Google Scholar
  • 7 Cleland J G, Daubert J C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure.  N Engl J Med. 2005;  352 1539-1549
    Google Scholar
  • 8 Daubert C, Gold M R, Abraham W T, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C. REVERSE Study Group. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.  J Am Coll Cardiol. 2009;  54 1837-1846
    Google Scholar
  • 9 Dickstein K, Bogale N, Priori S, Auricchio A, Cleland J G, Gitt A, Limbourg T, Linde C, van Veldhuisen D J, Brugada J. Scientific Committee; National Coordinators. The European cardiac resynchronization therapy survey.  Eur Heart J. 2009;  30 2450-2460
    Google Scholar
  • 10 Dickstein K, Vardas P E, Auricchio A. et al . ESC Committee for Practice Guidelines. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.  Europace. 2010;  12 1526-1536
    Google Scholar
  • 11 Doshi R N, Daoud E G, Fellows C, Turk K, Duran A, Hamdan M H, Pires L A. PAVE Study Group. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).  J Cardiovasc Electrophysiol. 2005;  16 1160-1165
    Google Scholar
  • 12 Farwell D, Patel N R, Hall A, Ralph S, Sulke A N. How many people with heart failure are appropriate for biventricular resynchronization?.  Eur Heart J. 2000;  21 1246-1250
    Google Scholar
  • 13 Hohnloser S H, Kuck K H, Dorian P, Roberts R S, Hampton J R, Hatala R, Fain E, Gent M, Connolly S J. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.  N Engl J Med. 2004;  351 2481-2488
    Google Scholar
  • 14 Jung W, Andresen D, Block M, Boecker D, Hohnloser S H, Kuck, Sperzel J. Leitlinien zur Implantation von Defibrillatoren.  Clin Res Cardiol. 2006;  95 696-708
    Google Scholar
  • 15 Linde C, Abraham W T, Gold M R, St. John Sutton M, Ghio S, Daubert C. REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.  J Am Coll Cardiol. 2008;  52 1834-1843
    Google Scholar
  • 16 Moss A J, Hall W J, Cannom D S. et al . MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events.  N Engl J Med. 2009;  361 1329-1338
    Google Scholar
  • 17 Moss A J, Zareba W, Hall W J. et al . Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.  N Engl J Med. 2002;  346 877-883
    Google Scholar
  • 18 Steinbeck G, Andresen D, Seidl K. et al, IRIS Investigators . Defibrillator implantation early after myocardial infarction.  N Engl J Med. 2009;  361 1427-1436
    Google Scholar
  • 19 Stellbrink C, Auricchio A, Diem B, Breithardt O A, Kloss M, Schöndube F A, Klein H, Messmer B J, Hanrath P. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.  Am J Cardiol. 1999;  83 143D-150D
    Google Scholar
  • 20 Stellbrink C, Breithardt O A, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R, Kramer A, Spinelli J. PATH-CHF (PAcing THerapies in Congestive Heart Failure) Investigators; CPI Guidant Congestive Heart Failure Research Group. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances.  J Am Coll Cardiol. 2001;  38 1957-1965
    Google Scholar
  • 21 Tang A S, Wells G A, Talajic M. et al . Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac resynchronization therapy for mild-to-moderate heart failure.  N Engl J Med. 2010;  363 2385-2395
    Google Scholar
  • 22 Wilkoff B L, Cook J R, Epstein A E. et al . Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial.  J Am Med Assoc. 2002;  288 3115-3123
    Google Scholar

Prof. Dr. med. Christoph Stellbrink

Klinik für Kardiologie und Internistische Intensivmedizin
Städtische Kliniken Bielefeld

Teutoburger Str. 50

33604 Bielefeld

Phone: 0521/5813401

Fax: 0521/5813498

      >